Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Assayag

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
ERJ Open Research|December 31, 2025
The clinical utility of elevated monocyte count in patients with fibrotic interstitial lung diseaseBohyung Min, Daniel-Costin Marinescu, Deborah Assayag, et al.
Chest|December 21, 2023
Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity PneumonitisMonica L Mullin, Gustavo Fernandez, Daniel-Costin Marinescu, et al.
The European Respiratory Journal|June 26, 2021
Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation studyTomoko Nakanishi, Agustin Cerani, Vincenzo Forgetta, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2025
Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research StatementDeborah Assayag, Ayodeji Adegunsoye, Yet H Khor, et al.
Annals of the American Thoracic Society|January 25, 2021
Treatment Initiation in Patients with Interstitial Lung Disease in CanadaDeborah Assayag, Kristopher Garlick, Kerri A Johannson, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
Respiratory Medicine|July 5, 2015
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosisDeborah Assayag, Eric Vittinghoff, Christopher J Ryerson, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
ERJ Open Research|December 31, 2025
The clinical utility of elevated monocyte count in patients with fibrotic interstitial lung diseaseBohyung Min, Daniel-Costin Marinescu, Deborah Assayag, et al.
Chest|December 21, 2023
Impact of Antigen Exposure on Outcomes and Treatment Response in Fibrotic Hypersensitivity PneumonitisMonica L Mullin, Gustavo Fernandez, Daniel-Costin Marinescu, et al.
The European Respiratory Journal|June 26, 2021
Genetically increased circulating FUT3 level leads to reduced risk of idiopathic pulmonary fibrosis: a Mendelian randomisation studyTomoko Nakanishi, Agustin Cerani, Vincenzo Forgetta, et al.
American Journal of Respiratory and Critical Care Medicine|November 24, 2021
Neighborhood-Level Disadvantage Impacts on Patients with Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2025
Particulate Matter Associations with Lung Function in Pulmonary SarcoidosisSharon E Kim, Deborah Assayag, Matthew Broerman, et al.
American Journal of Respiratory and Critical Care Medicine|December 1, 2025
Racial, Ethnic, Sex, and Gender Equity for Inclusive Interstitial Lung Disease Research: An Official American Thoracic Society Research StatementDeborah Assayag, Ayodeji Adegunsoye, Yet H Khor, et al.
Annals of the American Thoracic Society|January 25, 2021
Treatment Initiation in Patients with Interstitial Lung Disease in CanadaDeborah Assayag, Kristopher Garlick, Kerri A Johannson, et al.
ERJ Open Research|October 27, 2022
Neighbourhood disadvantage impacts on pulmonary function in patients with sarcoidosisGillian C Goobie, Christopher J Ryerson, Kerri A Johannson, et al.
Respiratory Medicine|July 5, 2015
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosisDeborah Assayag, Eric Vittinghoff, Christopher J Ryerson, et al.
JAMA Internal Medicine|October 17, 2022
Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung DiseaseGillian C Goobie, Christopher Carlsten, Kerri A Johannson, et al.
Pageof 7